DAFNA Capital Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.7M | Buy |
501,972
+57,974
| +13% | +$658K | 1.57% | 17 |
|
2025
Q1 | $2.95M | Buy |
443,998
+272,901
| +160% | +$1.81M | 0.84% | 31 |
|
2024
Q4 | $1.89M | Sell |
171,097
-36,330
| -18% | -$401K | 0.48% | 39 |
|
2024
Q3 | $2.55M | Hold |
207,427
| – | – | 0.6% | 41 |
|
2024
Q2 | $2.8M | Buy |
207,427
+62,427
| +43% | +$843K | 0.67% | 37 |
|
2024
Q1 | $1.96M | Buy |
+145,000
| New | +$1.96M | 0.45% | 46 |
|